https://www.live-feeds.com/feed/eqt-to-buy-molecular-testing-firm-qiagen-for-10-8-billionContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/eqt-to-buy-molecular-testing-firm-qiagen-for-10-8-billionhttps://www.live-feeds.com/feed/eqt-to-buy-molecular-testing-firm-qiagen-for-10-8-billion#u154380Sun, 25 Oct 2026 14:46:49 +0000Swedish private equity firm EQT has reached an agreement to buy molecular testing company Qiagen in a transaction valued at approximately EUR9.6 billion, or about $10.78 billion. The all-cash public takeover offer brings an end to years of takeover speculation surrounding the Dutch diagnostic group. Both companies announced the recommended voluntary agreement on Wednesday. The transaction highlights growing private equity interest in the life sciences sector, where robust demand for molecular testing technologies continues to spur consolidation and dealmaking activity after prior attempts by o